Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency

被引:43
作者
Corti, S. [1 ]
Bordoni, A. [1 ]
Ronchi, D. [1 ]
Musumeci, O. [3 ]
Aguennouz, M. [3 ]
Toscano, A. [3 ]
Lamperti, C. [1 ]
Bresolin, N. [1 ,2 ,4 ]
Comi, G. P. [1 ,2 ]
机构
[1] Univ Milan, IRCCS, Fdn Osped maggiore Policlin, Dept Neurol Sci, I-20122 Milan, Italy
[2] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20122 Milan, Italy
[3] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, I-98100 Messina, Italy
[4] IRCCS Eugenio Med, Lecce, Italy
关键词
carnitine palmitoyltransferase II; CPT2; genotype-phenotype; mutation; skeletal muscle; fatty acid oxidation;
D O I
10.1016/j.jns.2007.09.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Carnitine palmitoyltransferase II (CPT II) deficiency is the most common inherited disorder of lipid metabolism characterized in its adult form by attacks of myalgia and myoglobinuria. We analyzed a cohort of 22 CPT II-deficient patients (representing 20 independent probands) to correlate clinical presentation and molecular data. The common p.Serl 13Leu mutation was detected with an allelic frequency of 67.5% (27/40), in association with mild adult-onset phenotype. In addition to the p.Serl 13Leu mutation, other 10 disease-causing mutations were identified, 5 of which were novel. They are a micro-insertion within exon 5, three aminoacid substitutions within the coding region, namely p.Arg151Trp, p.Asp576Gly, p. Arg247Trp and a truncating stop codon mutation (p.Arg554Ter). Our data expand the spectrum of CPT II mutations and help to evaluate possible correlations between genotypes and phenotypes. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 27 条
[1]   CARNITINE [J].
BIEBER, LL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1988, 57 :261-283
[2]   Carnitine palmitoyltransferase deficiencies [J].
Bonnefont, JP ;
Demaugre, F ;
Prip-Buus, C ;
Saudubray, JM ;
Brivet, M ;
Abadi, N ;
Thuillier, L .
MOLECULAR GENETICS AND METABOLISM, 1999, 68 (04) :424-440
[3]   A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency [J].
Deschauer, M ;
Wieser, T ;
Schröder, R ;
Zierz, S .
MOLECULAR GENETICS AND METABOLISM, 2002, 75 (02) :181-185
[4]   Muscle carnitine palmitoyltransferase II deficiency - Clinical and molecular genetic features and diagnostic aspects [J].
Deschauer, M ;
Wieser, T ;
Zierz, S .
ARCHIVES OF NEUROLOGY, 2005, 62 (01) :37-41
[5]  
DIDONATO S, 2004, MYOLOGY, P1587
[6]   MUSCLE CARNITINE PALMITYLTRANSFERASE DEFICIENCY AND MYOGLOBINURIA [J].
DIMAURO, S ;
DIMAURO, PMM .
SCIENCE, 1973, 182 (4115) :929-931
[7]   CDNA CLONING, SEQUENCE-ANALYSIS, AND CHROMOSOMAL LOCALIZATION OF THE GENE FOR HUMAN CARNITINE PALMITOYLTRANSFERASE [J].
FINOCCHIARO, G ;
TARONI, F ;
ROCCHI, M ;
MARTIN, AL ;
COLOMBO, I ;
TARELLI, GT ;
DIDONATO, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :661-665
[8]   ASSIGNMENT OF THE HUMAN CARNITINE PALMITOYLTRANSFERASE-II GENE (CPT1) TO CHROMOSOME-1P32 [J].
GELLERA, C ;
VERDERIO, E ;
FLORIDIA, G ;
FINOCCHIARO, G ;
MONTERMINI, L ;
CAVADINI, P ;
ZUFFARDI, O ;
TARONI, F .
GENOMICS, 1994, 24 (01) :195-197
[9]   CARNITINE PALMITYLTRANSFERASE DEFICIENCY WITH PERMANENT WEAKNESS [J].
GIERON, MA ;
KORTHALS, JK .
PEDIATRIC NEUROLOGY, 1987, 3 (01) :51-53
[10]   Structural and mutational characterization of L-carnitine binding to human carnitine acetyltransferase [J].
Govindasamy, L ;
Kukar, T ;
Lian, W ;
Pedersen, B ;
Gu, YR ;
Agbandje-McKenna, M ;
Jin, SG ;
McKenna, R ;
Wu, DH .
JOURNAL OF STRUCTURAL BIOLOGY, 2004, 146 (03) :416-424